The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Nuclear Receptor ROR-Gamma Revenue 1.5 Market Analysis by Type 1.5.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 VPR-66 1.5.3 INV-17 1.5.4 GSK-2981278 1.5.5 BBI-6000 1.5.6 Others 1.6 Market by Application 1.6.1 Global Nuclear Receptor ROR-Gamma Market Share by Application: 2021-2026 1.6.2 Hospital 1.6.3 Clinic 1.6.4 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Nuclear Receptor ROR-Gamma Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Nuclear Receptor ROR-Gamma Market Players Profiles 3.1 4SC AG 3.1.1 4SC AG Company Profile 3.1.2 4SC AG Nuclear Receptor ROR-Gamma Product Specification 3.1.3 4SC AG Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Celgene Corporation 3.2.1 Celgene Corporation Company Profile 3.2.2 Celgene Corporation Nuclear Receptor ROR-Gamma Product Specification 3.2.3 Celgene Corporation Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Aurigene Discovery Technologies Limited 3.3.1 Aurigene Discovery Technologies Limited Company Profile 3.3.2 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Specification 3.3.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Advinus Therapeutics Ltd. 3.4.1 Advinus Therapeutics Ltd. Company Profile 3.4.2 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Specification 3.4.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Bristol-Myers Squibb Company 3.5.1 Bristol-Myers Squibb Company Company Profile 3.5.2 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Specification 3.5.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Arrien Pharmaceuticals, LLC 3.6.1 Arrien Pharmaceuticals, LLC Company Profile 3.6.2 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Specification 3.6.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Genfit SA 3.7.1 Genfit SA Company Profile 3.7.2 Genfit SA Nuclear Receptor ROR-Gamma Product Specification 3.7.3 Genfit SA Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Brickell Biotech, Inc. 3.8.1 Brickell Biotech, Inc. Company Profile 3.8.2 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Specification 3.8.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Biogen, Inc. 3.9.1 Biogen, Inc. Company Profile 3.9.2 Biogen, Inc. Nuclear Receptor ROR-Gamma Product Specification 3.9.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Genentech, Inc. 3.10.1 Genentech, Inc. Company Profile 3.10.2 Genentech, Inc. Nuclear Receptor ROR-Gamma Product Specification 3.10.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Nuevolution AB 3.11.1 Nuevolution AB Company Profile 3.11.2 Nuevolution AB Nuclear Receptor ROR-Gamma Product Specification 3.11.3 Nuevolution AB Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 Teijin Pharma Limited 3.12.1 Teijin Pharma Limited Company Profile 3.12.2 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Specification 3.12.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.13 GlaxoSmithKline Plc 3.13.1 GlaxoSmithKline Plc Company Profile 3.13.2 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Specification 3.13.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.14 Vitae Pharmaceuticals, Inc. 3.14.1 Vitae Pharmaceuticals, Inc. Company Profile 3.14.2 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Specification 3.14.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.15 Phenex Pharmaceuticals AG 3.15.1 Phenex Pharmaceuticals AG Company Profile 3.15.2 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Specification 3.15.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.16 Lead Pharma Holding B.V. 3.16.1 Lead Pharma Holding B.V. Company Profile 3.16.2 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Specification 3.16.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.17 Hanmi Pharmaceuticals, Co. Ltd. 3.17.1 Hanmi Pharmaceuticals, Co. Ltd. Company Profile 3.17.2 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Specification 3.17.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.18 Visionary Pharmaceuticals, Inc. 3.18.1 Visionary Pharmaceuticals, Inc. Company Profile 3.18.2 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Specification 3.18.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.19 Reata Pharmaceuticals, Inc. 3.19.1 Reata Pharmaceuticals, Inc. Company Profile 3.19.2 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Specification 3.19.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.20 Karo Bio AB 3.20.1 Karo Bio AB Company Profile 3.20.2 Karo Bio AB Nuclear Receptor ROR-Gamma Product Specification 3.20.3 Karo Bio AB Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Nuclear Receptor ROR-Gamma Market Competition by Market Players 4.1 Global Nuclear Receptor ROR-Gamma Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Market Players (2015-2020) 4.3 Global Nuclear Receptor ROR-Gamma Average Price by Market Players (2015-2020) 5 Global Nuclear Receptor ROR-Gamma Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Nuclear Receptor ROR-Gamma Market Size (2015-2020) 5.1.2 Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020) 5.1.3 North America Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 5.1.4 North America Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Nuclear Receptor ROR-Gamma Market Size (2015-2020) 5.2.2 Nuclear Receptor ROR-Gamma Key Players in East Asia (2015-2020) 5.2.3 East Asia Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 5.2.4 East Asia Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Nuclear Receptor ROR-Gamma Market Size (2015-2020) 5.3.2 Nuclear Receptor ROR-Gamma Key Players in Europe (2015-2020) 5.3.3 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 5.3.4 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Nuclear Receptor ROR-Gamma Market Size (2015-2020) 5.4.2 Nuclear Receptor ROR-Gamma Key Players in South Asia (2015-2020) 5.4.3 South Asia Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 5.4.4 South Asia Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Nuclear Receptor ROR-Gamma Market Size (2015-2020) 5.5.2 Nuclear Receptor ROR-Gamma Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 5.5.4 Southeast Asia Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Nuclear Receptor ROR-Gamma Market Size (2015-2020) 5.6.2 Nuclear Receptor ROR-Gamma Key Players in Middle East (2015-2020) 5.6.3 Middle East Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 5.6.4 Middle East Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Nuclear Receptor ROR-Gamma Market Size (2015-2020) 5.7.2 Nuclear Receptor ROR-Gamma Key Players in Africa (2015-2020) 5.7.3 Africa Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 5.7.4 Africa Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Nuclear Receptor ROR-Gamma Market Size (2015-2020) 5.8.2 Nuclear Receptor ROR-Gamma Key Players in Oceania (2015-2020) 5.8.3 Oceania Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 5.8.4 Oceania Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Nuclear Receptor ROR-Gamma Market Size (2015-2020) 5.9.2 Nuclear Receptor ROR-Gamma Key Players in South America (2015-2020) 5.9.3 South America Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 5.9.4 South America Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Nuclear Receptor ROR-Gamma Market Size (2015-2020) 5.10.2 Nuclear Receptor ROR-Gamma Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 5.10.4 Rest of the World Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 6 Global Nuclear Receptor ROR-Gamma Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Nuclear Receptor ROR-Gamma Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Nuclear Receptor ROR-Gamma Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Nuclear Receptor ROR-Gamma Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Nuclear Receptor ROR-Gamma Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Nuclear Receptor ROR-Gamma Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Nuclear Receptor ROR-Gamma Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Nuclear Receptor ROR-Gamma Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Nuclear Receptor ROR-Gamma Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Nuclear Receptor ROR-Gamma Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Nuclear Receptor ROR-Gamma Consumption by Countries 7 Global Nuclear Receptor ROR-Gamma Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Nuclear Receptor ROR-Gamma (2021-2026) 7.2 Global Forecasted Revenue of Nuclear Receptor ROR-Gamma (2021-2026) 7.3 Global Forecasted Price of Nuclear Receptor ROR-Gamma (2021-2026) 7.4 Global Forecasted Production of Nuclear Receptor ROR-Gamma by Region (2021-2026) 7.4.1 North America Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026) 7.4.3 Europe Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026) 7.4.7 Africa Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026) 7.4.9 South America Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Nuclear Receptor ROR-Gamma by Application (2021-2026) 8 Global Nuclear Receptor ROR-Gamma Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country 8.2 East Asia Market Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country 8.3 Europe Market Forecasted Consumption of Nuclear Receptor ROR-Gamma by Countriy 8.4 South Asia Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country 8.5 Southeast Asia Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country 8.6 Middle East Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country 8.7 Africa Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country 8.8 Oceania Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country 8.9 South America Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country 8.10 Rest of the world Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country 9 Global Nuclear Receptor ROR-Gamma Sales by Type (2015-2026) 9.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Type (2015-2020) 9.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Type (2021-2026) 10 Global Nuclear Receptor ROR-Gamma Consumption by Application (2015-2026) 10.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Application (2015-2020) 10.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Application (2021-2026) 11 Global Nuclear Receptor ROR-Gamma Manufacturing Cost Analysis 11.1 Nuclear Receptor ROR-Gamma Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Nuclear Receptor ROR-Gamma 12 Global Nuclear Receptor ROR-Gamma Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Nuclear Receptor ROR-Gamma Distributors List 12.3 Nuclear Receptor ROR-Gamma Customers 12.4 Nuclear Receptor ROR-Gamma Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : Apr 2024 |
Category : Manufacturing and Construction | Pages : 116 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 254 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Energy, Mining and Utilities | Pages : 233 |
Price : US$ 3,500 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 145 |
Price : US$ 3,500 | Date : Feb 2024 |
Category : Energy, Mining and Utilities | Pages : 100 |
We will be happy to help you find what you need. Please call us or write to us: